TY - JOUR
T1 - Diagnostic stewardship and the coronavirus disease 2019 (COVID-19) pandemic
T2 - Lessons learned for prevention of emerging infectious diseases in acute-care settings
AU - Epstein, Lauren
AU - Diekema, Daniel J.
AU - Morgan, Daniel J.
AU - Fakih, Mohamad G.
AU - Lee, Francesca
AU - Gottlieb, Lindsey
AU - Leung, Elizabeth
AU - Yen, Christina F
AU - Sullivan, Kaede V.
AU - Hayden, Mary K.
N1 - Publisher Copyright:
© The Author(s), 2023.
PY - 2024/3/7
Y1 - 2024/3/7
N2 - Executive summary The coronavirus disease 2019 (COVID-19) pandemic has demonstrated the importance of stewardship of viral diagnostic tests to aid infection prevention efforts in healthcare facilities. We highlight diagnostic stewardship lessons learned during the COVID-19 pandemic and discuss how diagnostic stewardship principles can inform management and mitigation of future emerging pathogens in acute-care settings. Diagnostic stewardship during the COVID-19 pandemic evolved as information regarding transmission (eg, routes, timing, and efficiency of transmission) became available. Diagnostic testing approaches varied depending on the availability of tests and when supplies and resources became available. Diagnostic stewardship lessons learned from the COVID-19 pandemic include the importance of prioritizing robust infection prevention mitigation controls above universal admission testing and considering preprocedure testing, contact tracing, and surveillance in the healthcare facility in certain scenarios. In the future, optimal diagnostic stewardship approaches should be tailored to specific pathogen virulence, transmissibility, and transmission routes, as well as disease severity, availability of effective treatments and vaccines, and timing of infectiousness relative to symptoms. This document is part of a series of papers developed by the Society of Healthcare Epidemiology of America on diagnostic stewardship in infection prevention and antibiotic stewardship.
AB - Executive summary The coronavirus disease 2019 (COVID-19) pandemic has demonstrated the importance of stewardship of viral diagnostic tests to aid infection prevention efforts in healthcare facilities. We highlight diagnostic stewardship lessons learned during the COVID-19 pandemic and discuss how diagnostic stewardship principles can inform management and mitigation of future emerging pathogens in acute-care settings. Diagnostic stewardship during the COVID-19 pandemic evolved as information regarding transmission (eg, routes, timing, and efficiency of transmission) became available. Diagnostic testing approaches varied depending on the availability of tests and when supplies and resources became available. Diagnostic stewardship lessons learned from the COVID-19 pandemic include the importance of prioritizing robust infection prevention mitigation controls above universal admission testing and considering preprocedure testing, contact tracing, and surveillance in the healthcare facility in certain scenarios. In the future, optimal diagnostic stewardship approaches should be tailored to specific pathogen virulence, transmissibility, and transmission routes, as well as disease severity, availability of effective treatments and vaccines, and timing of infectiousness relative to symptoms. This document is part of a series of papers developed by the Society of Healthcare Epidemiology of America on diagnostic stewardship in infection prevention and antibiotic stewardship.
UR - http://www.scopus.com/inward/record.url?scp=85176582380&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85176582380&partnerID=8YFLogxK
U2 - 10.1017/ice.2023.195
DO - 10.1017/ice.2023.195
M3 - Article
C2 - 37933951
AN - SCOPUS:85176582380
SN - 0899-823X
VL - 45
SP - 277
EP - 283
JO - Infection Control and Hospital Epidemiology
JF - Infection Control and Hospital Epidemiology
IS - 3
ER -